Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation

被引：12
|
作者：
Wahie, S [1 ]
Alexandroff, A [1 ]
Reynolds, NJ [1 ]
Meggitt, SJ [1 ]
机构：
[1] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2006年 / 154卷 / 01期
关键词：
D O I：
10.1111/j.1365-2133.2005.07026.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：194 / 195
页数：3
相关论文
共 50 条
  • [21] Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation
    Ikeda, Takashi
    Mori, Keita
    Kawamura, Koji
    Mori, Takehiko
    Hagiwara, Shotaro
    Ueda, Yasunori
    Kahata, Kaoru
    Uchida, Naoyuki
    Tsukada, Nobuhiro
    Murakami, Satoshi
    Yamamoto, Masahide
    Takahashi, Tsutomu
    Ichinohe, Tatsuo
    Onizuka, Makoto
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    Okamoto, Shinichiro
    Sunami, Kazutaka
    Takamatsu, Hiroyuki
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 586 - 594
  • [22] Autologous non-myeloablative hematopoietic stem cell transplantation for diffuse scleroderma
    Oyama, Y
    Statkute, L
    Barr, WG
    Krosnjar, N
    Yaung, K
    Weppner, C
    Burt, RK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 90 - 91
  • [23] Safety and efficacy of autologous non-myeloablative hemopoietic stem cell transplantation
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) : 457 - 457
  • [24] Imatinib therapy prior to myeloablative allogeneic stem cell transplantation
    Zaucha, JM
    Prejzner, W
    Giebel, S
    Gooley, TA
    Szatkowski, D
    Kalwak, K
    Wojnar, J
    Kruzel, T
    Balon, J
    Holowiecki, J
    Hellmann, A
    BONE MARROW TRANSPLANTATION, 2005, 36 (05) : 417 - 424
  • [25] Autologous non-myeloablative hematopoietic stem cell transplantation for diffuse scleroderma
    Oyama, Y
    Statkute, L
    Barr, W
    Traynor, A
    Burt, R
    BLOOD, 2005, 106 (11) : 819A - 819A
  • [26] Imatinib therapy prior to myeloablative allogeneic stem cell transplantation
    J M Zaucha
    W Prejzner
    S Giebel
    T A Gooley
    D Szatkowski
    K Kałwak
    J Wojnar
     T Krużel
    J Balon
    J Hołowiecki
    A Hellmann
    Bone Marrow Transplantation, 2005, 36 : 417 - 424
  • [27] Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
    Porter, DL
    Luger, SM
    Duffy, KM
    Stadtmauer, EA
    Laport, G
    Schuster, SJ
    Orloff, G
    Tsai, D
    McDaid, K
    Kathakali, A
    Leonard, DGB
    Antin, JH
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (04) : 230 - 238
  • [28] Pegfilgrastim after autologous stem cell transplantation
    Rinaldi, CR
    Becchimanzi, C
    Risitano, AM
    Marra, N
    Rotoli, B
    De Rosa, G
    BONE MARROW TRANSPLANTATION, 2006, 37 : S307 - S307
  • [29] Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma
    Braiteh, Fadi
    Hymes, Sharon R.
    Giralt, Sergio A.
    Jones, Roy
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) : 4511 - 4513
  • [30] Autologous haematopoietic stem cell transplantation in multiple sclerosis: myeloablative versus non-myeloablative conditioning regimens
    Motuzova, Y.
    Fedulov, A.
    Uss, A.
    Milanovich, N.
    Zmachinsky, V.
    Baida, A.
    Minzer, M.
    Chernysh, E.
    Bulaev, I.
    Smolnikova, V.
    Drazhina, L.
    Solovieva, N.
    JOURNAL OF NEUROLOGY, 2010, 257 : S150 - S150
12345